By performing non-viral pooled knock-in screens, UCSF investigators have discovered novel genes that improve T cell functionality across a variety of in vitro assays. This invention includes novel compositions and methods for modifying the genome of a T cell to alter its specific and functionality, while limiting the side effects associated with T cell therapies.
Technology Advantages:
Patent Pending
T cell therapy, Cancer, Immunotherapy